AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Viveve Medical, Inc.

$0 +$0.00 (+100.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
2.15K
AVG Volume
1.89K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
02M4M6M8M20 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
22 Q36.83M
22 Q26.76M
22 Q16.62M
21 Q46.43M
21 Q36.67M
21 Q26.58M
21 Q15.62M
20 Q45.48M
20 Q34.98M
20 Q24.51M
Net Income (USD) · TTM
-40M-30M-20M-10M020 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
22 Q3-23.92M
22 Q2-24.49M
22 Q1-22.41M
21 Q4-22.03M
21 Q3-20.45M
21 Q2-18.33M
21 Q1-21.4M
20 Q4-21.91M
20 Q3-31.98M
20 Q2-36.2M
Operating Income (USD) · TTM
-30M-20M-10M020 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
22 Q3-21.14M
22 Q2-21.97M
22 Q1-21.9M
21 Q4-21.55M
21 Q3-19.89M
21 Q2-17.8M
21 Q1-17.8M
20 Q4-18.5M
20 Q3-21.23M
20 Q2-24.35M
EBITDA (USD) · TTM
-40M-30M-20M-10M020 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
22 Q3-20.43M
22 Q2-21.24M
22 Q1-19.77M
21 Q4-19.61M
21 Q3-17.98M
21 Q2-15.79M
21 Q1-18.86M
20 Q4-19.32M
20 Q3-28.63M
20 Q2-31.8M
Cash Flows (USD) · TTM
-30M-20M-10M020 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
22 Q3-16.83M
22 Q2-16.03M
22 Q1-15.13M
21 Q4-13.33M
21 Q3-12.49M
21 Q2-12.6M
21 Q1-13.46M
20 Q4-16.02M
20 Q3-18.95M
20 Q2-22.83M
EPS (USD) · TTM
-200-150-100-50020 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
22 Q3-2.29
22 Q2-2.34
22 Q1-2.15
21 Q4-2.24
21 Q3-3.8
21 Q2-5.32
21 Q1-9.95
20 Q4-16.35
20 Q3-35.1
20 Q2-168.11
Expenses (USD) · TTM
010M20M30MR&DSG&ACapex20 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
22 Q322.86M
22 Q223.14M
22 Q122.88M
21 Q422.63M
21 Q321.34M
21 Q219.4M
21 Q119M
20 Q419.57M
20 Q321.8M
20 Q224.65M
Shares Outstanding (USD) · TTM
-6M-4M-2M0Buybacks (Repurchases)Stock-Based Compensation20 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q3
VIVE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
22 Q3-4.47M
22 Q2-4.69M
22 Q1-4.65M
21 Q4-4.48M
21 Q3-3.75M
21 Q2-3.3M
21 Q1-3.09M
20 Q4-2.99M
20 Q3-2.77M
20 Q2-2.65M
Employee Count
0501001502012201320142015201620172018201920202021
VIVE Employee Count by quarter
PeriodEmployee Count
202147
202042
201955
201867
2017103
201642
201521
20149
20136
20128
PE Ratio
02.557.510med 1.95Jan 14Mar 14Jun 14Aug 14Oct 14Jan 15Mar 15
VIVE PE Ratio by quarter
PeriodPE Ratio
Mar 154.56
Mar 155.07
Feb 155.7
Feb 155.33
Feb 157.16
Feb 155.98
Jan 157.42
Jan 155.85
Jan 156.5
Jan 156.11
Jan 156.37
Dec 144.81
Dec 144.55
Dec 144.55
Dec 146.24
Nov 145.48
Nov 148.85
Nov 146.5
Nov 140.31
Oct 140.41
Oct 140.45
Oct 140.5
Oct 140.43
Oct 140.46
Sep 140.32
Sep 140.54
Sep 141.02
Sep 141.07
Aug 140.48
Aug 140.3
Aug 140.27
Aug 140.11
Aug 140.13
Jul 140.08
Jul 140.14
Jul 140.13
Jul 140.14
Jun 140.12
Jun 140.14
Jun 140.14
Jun 140.09
May 140.1
May 140.1
May 140.09
May 141.07
May 141.09
Apr 141.73
Apr 141.73
Apr 141.87
Apr 141.87
Mar 142.07
Mar 141.87
Mar 141.87
Mar 142.37
Feb 142.13
Feb 142.07
Feb 142.47
Feb 142.12
Jan 141.97
Jan 142.09
Jan 142.27
Jan 142.17
Jan 142.12
Dec 131.92
Dec 132.17
Dec 132.29
Dec 132.37
Nov 132.47
Nov 132.66
Nov 132.52
Free Cash Flow Yield
-2000000%-1500000%-1000000%-500000%0%med -788858.58%Jan 25May 25Sep 25Jan 26May 26Sep 26
VIVE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-788858.56%
Sep 26-788858.58%
Aug 26-788858.56%
Aug 26-788858.56%
Aug 26-788858.58%
Aug 26-788858.56%
Jul 26-788858.58%
Jul 26-788858.58%
Jul 26-788858.58%
Jul 26-788858.58%
Jul 26-788858.58%
Jun 26-788858.56%
Jun 26-788858.56%
Jun 26-788858.56%
Jun 26-788858.58%
May 26-788858.58%
May 26-788858.58%
May 26-788858.58%
May 26-788858.58%
May 26-788858.58%
Apr 26-788858.58%
Apr 26-788858.58%
Apr 26-788858.58%
Apr 26-788858.58%
Mar 26-788858.58%
Mar 26-788858.58%
Mar 26-788858.58%
Mar 26-788858.58%
Feb 26-788858.58%
Feb 26-788858.58%
Feb 26-788858.58%
Feb 26-525905.68%
Jan 26-788858.58%
Jan 26-788858.58%
Jan 26-788858.58%
Jan 26-788858.58%
Jan 26-1577717.17%
Dec 25-1577717.17%
Dec 25-1577717.17%
Dec 25-788858.58%
Dec 25-175301.91%
Nov 25-1577717.17%
Nov 25-1577717.17%
Nov 25-1577717.17%
Nov 25-1577717.17%
Oct 25-1577717.17%
Oct 25-1577717.17%
Oct 25-1577717.17%
Oct 25-1577717.17%
Oct 25-1577717.17%
Sep 25-788858.58%
Sep 25-788858.58%
Sep 25-1577717.17%
Sep 25-1577717.17%
Aug 25-1577717.17%
Aug 25-1577717.17%
Aug 25-1577717.17%
Aug 25-1577717.17%
Aug 25-1577717.17%
Jul 25-1577717.17%
Jul 25-1577717.17%
Jul 25-1577717.17%
Jul 25-1577717.17%
Jun 25-1577717.17%
Jun 25-157771.71%
Jun 25-1577717.17%
Jun 25-1577717.17%
May 25-1577717.17%
May 25-1577717.17%
May 25-788858.58%
May 25-788858.58%
May 25-788858.58%
Apr 25-788858.58%
Apr 25-788858.58%
Apr 25-788858.58%
Apr 25-788858.58%
Mar 25-788858.58%
Mar 25-788858.58%
Mar 25-1577717.17%
Mar 25-1577717.17%
Feb 25-1577717.17%
Feb 25-788858.58%
Feb 25-1577717.17%
Feb 25-788858.58%
Jan 25-788858.58%
Jan 25-788858.58%
Jan 25-788858.58%
Jan 25-788858.58%
Jan 25-788858.58%
Dec 24-788858.58%
Dec 24-525905.68%
Dec 24-1577717.17%
Dec 24-1577717.17%
Nov 24-394429.29%
Nov 24-394429.29%
Nov 24-175301.91%
Nov 24-394429.29%
Nov 24-394429.29%
Oct 24-315543.41%
Oct 24-315543.41%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VIVE Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Price to Book
000.010.010.01med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VIVE Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250.01
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250.01
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240.01
Nov 240
Nov 240
Oct 240
Oct 240
Viveve Medical, Inc.
VIVE
Stockpicker

Video analysis: VIVE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.